期刊文献+

急性冠脉综合征患者超敏C-反应蛋白、脂蛋白a、脂联素的悬浮芯片技术集成检测及其意义 被引量:5

下载PDF
导出
摘要 目的:检测急性冠脉综合征(ACS)患者血中超敏C-反应蛋白(hs-CRP)、脂蛋白a[Lp(a)]及脂联素(APN)3种蛋白因子的浓度并探讨其临床意义。方法:用悬浮芯片技术集成检测116例ACS患者(ACS组)hs-CRP、Lp(a)及APN3种蛋白因子的浓度,并与30例单纯稳定型心绞痛患者(SAP组)及35例正常人群(NC组)进行对照。结果:ACS组hs-CRP、Lp(a)较SAP组及NC组浓度均增高,APN值则明显降低(均P<0.05),其中ACS组中AMI组hs-CRP、Lp(a)浓度高于UAP组,APN值低于UAP组(均P<0.05)。ACS各亚组中预后不良患者hs-CRP、Lp(a)水平高于预后良好者(均P<0.001),而APN浓度则显著低于预后良好患者(P<0.01)。hs-CRP、Lp(a)的含量与斑块不稳定程度呈显著正相关关系(r=0.592,P<0.001;r=0.385,P<0.001),APN的含量与斑块不稳定程度则呈显著负相关关系(r=-0.627,P<0.001)。结论:hs-CRP、Lp(a)、APN可能参与ACS病变全过程,与ACS临床类型及其预后高度相关,因此可用来预测ACS的病变稳定程度和心血管事件发生的危险度,从而判断预后。
出处 《实用医学杂志》 CAS 北大核心 2010年第1期61-63,共3页 The Journal of Practical Medicine
基金 广东省科技计划项目(编号:2007B03150810)
  • 相关文献

参考文献14

  • 1Naghavi M, Falk E, Hecht H S, et al. From vulnerable plaque to vulnerable patient-Part Ⅲ: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report [J]. Am J Cardiol, 2006, 98(2A) :2H-15H.
  • 2Kosnge M, Kimnra K, Ishikawa T, et al. Differences in inflammatory activity at the onset of acute myocardial infarction according to the clinical presentation of preinfarction angina [J]. Jpn Circ J, 2001,65(8) :707-710.
  • 3Folsom A R, Chambless L E, Ballantyne C M, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study [J]. Arch Intern Med, 2006, 166(13) : 1368-1373.
  • 4Folsom A R, Aleksic N, Catellier D, et al. C-reactive protein and incident coronary heart disease in the Atheroselerosis Risk In Communities (ARIC) study [J]. Am Heart J, 2002, 144(2):233- 238.
  • 5崔丽艳,刘迪,吴永华,张捷.缺血修饰白蛋白和C反应蛋白在急性冠脉综合征诊断中的作用[J].实用医学杂志,2007,23(21):3331-3333. 被引量:9
  • 6林肇得,冯新武,邓斌,陈平,刘健.超敏C-反应蛋白与急性冠脉综合征患者预后的关系[J].实用医学杂志,2007,23(15):2329-2331. 被引量:5
  • 7张丽霞,只野寿太郎,山本匡介.脂蛋白(a)是最敏感的急性时相蛋白[J].中华医学检验杂志,1997,20(3):167-168. 被引量:85
  • 8Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies [J]. Circulation, 2000, 102(10) : 1082-1085.
  • 9Angles-Cano E. Structural basis for the pathophysiology of lipoprotein (a) in the athero-thrombotic process [J]. Braz J Med Biol Res, 1997, 30(11) : 1271-1280.
  • 10Igarashi Y, Yamaura M, Ito M, et al. Elevated serum lipoprotein (a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophageal echoeardiographie study [J]. Am Heart J, 1998, 136(6):965-971.

二级参考文献57

共引文献100

同被引文献66

  • 1Imatoh T,Miyazaki M,Momose Y,et al.Adiponectin levels associated with the development of hypertension:a prospective study[J].Hypertension Res,2008,31(2):229-233.
  • 2Okamoto Y,Arita Y,Nishida M,et al.An adipocyte-derived plasma protein,adiponectin,adheres to injured vascular walls[J].Horm Metab Res,2000,32(2):47-50.
  • 3Yasunari K,Maeda K,Nakamura M,et al.Oxidative stress in leukocytes is a possible link between blood pressure,blood glucose and C-reactive protein[J].Hypertension,2002,39(3):777.
  • 4Anan F,Shimomura T,Kaku T,et al.High-sensitivity Creactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis[J].Metabolism.2008,57(l):66-70.
  • 5Hayaishi O R,Yamasaki Y,Katakami N,et al.Elevated C reactive protein associates with early stage carotid atherosclerosis in young subjects with type 1 diabetes[J].Diabetes Care,2002,25(8):1432-1438.
  • 6UMA SINGH, ISHWARLAL JIALAL. Oxidative stress and athero- sclerosis[ J]. Pathophysiology ,2006,13 : 129 - 142.
  • 7MANFREDI RIZZO, JELENA KOTUR - STEVULJEVIC, KASPARBERNEIS,et al. Atherogenic dyslipidemia and oxidative stress: a new look [ J]. Translational Research ,2009,153:217 - 223.
  • 8RODRiGUEZ G, MAGO N, ROSA F. Role of inflammation in atherogenesis [ J ]. Invest Clin. 2009,50 ( 1 ) : 109 - 129.
  • 9ESTERBAUER H,SCHAUR RJ,ZOLLNE RH, Chemistry and bio- chemistry of 4 - hydroxynonenal, malondialdehyde and related al- dehydes [ J ]. Free Radical Biol Med, 1991,11:81 - 128.
  • 10AKKUS I, SAGLAM NI, CAGLAYAM O, VURAL A, KALAN S, SAGLAM M. Investigation of erythrocyte membrane lipid peroxida- tion and antioxidant defense systems of patients with coronary arter- y disease (CAD) documented by angiography [ J ]. Clin Chim Acta, 1996,244 : 173 - 180.

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部